QR koda

Deferasirox in Indian children with thalassemia major: 3 years experience

Objective: To evaluate the efficacy and safety of the oral iron chelator deferasirox in treating transfusional hemosiderosis in a cohort of Indian children with thalassemia major with high iron load. Materials and Methods: The first 50 children (age 2-18 yrs) with thalassemia major to commence defer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Principais autores: Mayank Dhamija, Amita Mahajan, Manas Kalra, Anju Virmani
Format: Artigo
Jezik:Inglês
Izdano: Thieme Medical and Scientific Publishers Pvt. Ltd. 2013-01-01
Serija:Indian Journal of Medical and Paediatric Oncology
Teme:
Online dostop:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=1;spage=16;epage=20;aulast=Dhamija
Oznake: Označite
Brez oznak, prvi označite!